Comments
Loading...
XBiotech Analyst Ratings and Price Targets | NASDAQ:XBIT | Benzinga
XBiotech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for XBiotech Corp from these most-recent analyst ratings.
Analyst Ratings for XBiotech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for XBiotech (XBIT) stock?
There is no price target for XBiotech
What is the most recent analyst rating for XBiotech (XBIT)?
There is no analyst for XBiotech
When was the last upgrade for XBiotech (XBIT)?
There is no last upgrade for XBiotech
When was the last downgrade for XBiotech (XBIT)?
There is no last downgrade for XBiotech.
When is the next analyst rating going to be posted or updated for XBiotech (XBIT)?
There is no next analyst rating for XBiotech.
Is the Analyst Rating XBiotech (XBIT) correct?
There is no next analyst rating for XBiotech.
Browse analyst ratings and price targets on all stocks.
